Get the Daily Brief

All action, no filler. BioBriefs delivers the industry’s 10 must-know updates, every morning.

Latest Biotech News

Deal and financing signals in pharma

October 04, 2026

Merck, Novo, and Novartis are moving deeper into early-stage China partnering, with multiple deals now structured around assets earlier in development than in prior cycles, according to...

Regenerative autophagy control in disease biology

October 04, 2026

Hydrogen sulfide is shown to enhance wheat resistance to stripe rust by activating the autophagy pathway. Researchers report that H2S increases TaATG6c persulfidation, effectively turning on...

Autophagy master regulator becomes drug target

October 04, 2026

A Nature study from TIGEM maps a previously unknown TBK1–ULK1 signaling route that controls TFEB, the master regulator of lysosomal biogenesis and autophagy. The group identifies druggable points...

Cancer imaging biomarkers for relapse prediction

October 04, 2026

FDG PET/CT is being combined with clinical and pathology variables to refine relapse risk in MALT lymphoma. Researchers in Wuhan developed a prognostic nomogram that integrates imaging metabolism...

Precision delivery and computational screening for RNA-LNPs

October 04, 2026

The University of Catania introduces a modular computational framework to rank safer RNA-lipid nanoparticle formulations before any lab testing. The method uses virtual patients, machine learning,...

Clinical protocol optimization in oncology imaging

October 04, 2026

A two-sequence abbreviated liver MRI protocol shows strong accuracy for detecting tumor return after microwave ablation. Researchers report 87.5% sensitivity and 97.6% specificity for recurrent...

Drug-safety and surveillance signals in biologics

October 04, 2026

Safety scrutiny around biologic drugs is widening after a signal in FDA records points to hair loss as a potential adverse effect category under closer monitoring. The report frames the...

Innovative clinical strategy in hematologic oncology

October 04, 2026

A phase 2 trial reports strong early outcomes for an intensified targeted-drug approach in early-stage classical Hodgkin lymphoma. A regimen pairing two targeted agents with a reduced chemotherapy...

Regimen timing and combination rationale in breast cancer

October 04, 2026

An oral combination strategy expands treatment options in metastatic breast cancer. Results from the phase 3 evERA study in the New England Journal of Medicine show that adding giredestrant, a...

Drug-delivery and biosafety for nanomedicine

October 04, 2026

Encrypted cancer genomics and homomorphic encryption benchmarks are addressing the gap between privacy-preserving computation and practical deployment. A new BMC Bioinformatics benchmark evaluates...

Oncology: immunotherapy + chemo improves outcomes in recurrent cervical cancer

October 04, 2026

A retrospective Chinese study reports that adding the PD-1 inhibitor tislelizumab to paclitaxel–carboplatin and bevacizumab significantly improved response rates and survival in patients with...

Neurology: intranasal BMP2/6 aims to slow dopamine neuron loss in Parkinson’s models

October 04, 2026

A new preclinical study in BMC Medicine reports that intranasally delivered recombinant BMP2/6 proteins delayed dopaminergic neuron degeneration and improved motor function in mouse models of...

Hematology/Oncology trials: kidney-aimed immunotherapy and first-line signals in CLL

October 04, 2026

Two separate hematology and oncology signals highlight rapid momentum in late-stage and early clinical development. First, a report on a leukemia program describes how recent phase 3 data for the...

Medical imaging and diagnostics: breath test reaches high accuracy for lung cancer detection

October 04, 2026

A landmark clinical trial reports that a breath-based test detected lung cancer with over 90% accuracy, aiming to address the persistent gap between symptom onset and diagnosis. With lung cancer...

Cancer biomarkers and risk models: emotional distress predicts survival in lung cancer surgery patients

October 04, 2026

A multicenter study of 167 lung cancer patients found that persistent emotional distress across neoadjuvant therapy and surgery was independently associated with worse overall and progression-free...

Regenerative/neuroprotective engineering: engineered exosomes for spinal cord injury

October 04, 2026

Researchers report that engineered exosomes can deliver regenerative cargo directly to neural stem cells after spinal cord injury, aiming to improve functional repair in a setting defined by...

Rare disease therapy approach: gene-targeted complement silencing in myasthenia gravis

October 04, 2026

A rat study reports that gene silencing of complement C3 using GalNAc-targeted siRNA nearly eliminated plasma complement, preserved acetylcholine receptor levels, and reduced muscle weakness in a...

GLP-1 obesity evidence: NIH backs $4M study on weight regain after stopping GLP-1 drugs

October 04, 2026

The NIH awarded UTHealth Houston researchers a five-year $4 million grant to study why weight returns after discontinuation of GLP-1 receptor agonists. The project is led by Absalon J. Pineda and...

Platform/innovation: single-clone selection improves manufacturability for cell therapy

October 04, 2026

Researchers report that a miniaturized semi-perfusion clone screening method and a multi-parameter manufacturability index can improve clone ranking consistency across scales compared with...

Regulatory science: FDA plans to add aging and longevity to FARS update

October 04, 2026

The FDA said it plans to include aging and longevity among the topics highlighted in an upcoming update to its Focus Areas of Regulatory Science (FARS) report. FDA Chief Scientist Steven Kozlowski...